Cogent Biosciences, Inc. (COGT) › Total AssetsCogent Biosciences, Inc. (COGT) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $49.12M2018: $85.93M2019: $49.42M2020: $250.92M2021: $232.09M2022: $300.81M2023: $313.44M2024: $327.90M2025: $937.61M$937.61M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$937.61M+185.9%2024$327.90M+4.6%2023$313.44M+4.2%2022$300.81M+29.6%2021$232.09M-7.5%2020$250.92M+407.7%2019$49.42M-42.5%2018$85.93M+75.0%2017$49.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share